Studies on the usefulness of the metabolic imaging against arterial chemoradiation therapy for head and neck cancer

Studies on the usefulness of the metabolic imaging against arterial chemoradiation therapy for head and neck cancer - Methionine PET study for head and neck cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005000

Enrollment

Registered

2011-02-03

Start date

2011-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

head and neck cancer

Interventions

Methionin PET imaging

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who can receive a conventional arterial infusion chemotherapy and radiotherapy

Exclusion criteria

Exclusion criteria: Patients who can not receive a conventional arterial infusion chemotherapy and radiotherapy

Design outcomes

Primary

Measure	Time frame
MET-PET,FDG-PET,CT,MRI,angiography imaging	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026